Summary of Product Characteristics
last updated on the eMC:
12/01/2012
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 12/01/2012 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 5.1 - Pharmacodynamic Properties
|
| Date of revision of text on the SPC: 24-Jun-2011 |
| Legal Category: P, GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Section 5.1 updated to include ongoing protection from and prevention of dentinal hypersensitivity
|
|
Updated on 19/10/2011 and displayed until 12/01/2012
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic indications
|
| Date of revision of text on the SPC: 23-Mar-2011 |
| Legal Category: P, GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Section 4.1 - addition of 'prevention of the pain of dentinal hypersensitivity' and 'ongoing protection from dentinal hypersensitivity'
|
|
Updated on 27/01/2010 and displayed until 19/10/2011
|
Reasons for adding or updating:
|
|
|
| Date of revision of text on the SPC: |
| Legal Category: P, GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
